Biogena Group Invest AG (WBO:BIO) Cash And Cash Equivalents : €0.02 Mil (As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Cash And Cash Equivalents?

Biogena Group Invest AG's quarterly cash and cash equivalents increased from Jan. 2022 (€0.02 Mil) to Jan. 2023 (€0.02 Mil) but then stayed the same from Jan. 2023 (€0.02 Mil) to Jan. 2024 (€0.02 Mil).

Biogena Group Invest AG's annual cash and cash equivalents increased from Jan. 2022 (€0.02 Mil) to Jan. 2023 (€0.02 Mil) but then declined from Jan. 2023 (€0.02 Mil) to Jan. 2024 (€0.02 Mil).

Biogena Group Invest AG Cash And Cash Equivalents Historical Data

The historical data trend for Biogena Group Invest AG's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Cash And Cash Equivalents Chart

Biogena Group Invest AG Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Cash And Cash Equivalents

0.21

0.02

Biogena Group Invest AG Semi-Annual Data
	Jan21	Jan22	Jan23	Jan24
Cash And Cash Equivalents	0.21	0.02	0.02	0.02

Biogena Group Invest AG Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Biogena Group Invest AG (WBO:BIO) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Biogena Group Invest AG Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogena Group Invest AG (WBO:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

Strubergasse 24, Salzburg, AUT, 5020

Website

https://www.biogenagroup.com

Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.